跳至主要内容
临床试验/NCT00588107
NCT00588107已完成不适用

Partnership for Health: A Web-Based Smoking Intervention For Cancer Survivors

Dana-Farber Cancer Institute2 个研究点 分布在 1 个国家目标入组 374 人开始时间: 2005年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
374
试验地点
2
主要终点
The primary outcome is smoking cessation

研究概览

简要总结

The purpose of this study was to compare two different ways of helping people who have had childhood cancer, leukemia, tumors or similar illnesses learn health information and information about trying to quit smoking. All participants received materials in the mail about their health, survivorship, and smoking. Some participants were also invited to use a website. The goal of the study was to see which is a better way to get information about health issues, survivorship, and smoking.

详细描述

The study was a randomized controlled trial with two groups. It was designed to demonstrate the efficacy and cost-effectiveness of a Web-based format of the PFH intervention, compared to a written Materials control condition. The study was conducted among childhood and young adult cancer survivors, who smoke, at four survivor clinics. Participants in both conditions received access to pharmacotherapy at no cost. Participants in the Web condition received access to an interactive Web site that focuses on survivorship, health, and smoking.

Participants in the Web condition received access to an interactive Web site that focuses on survivorship, health, and smoking. Participants in the Materials control group received tailored and targeted print materials.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Have been diagnosed with cancer before age 35
  • Currently be ≥ 18 years of age and ≤ 55 years of age
  • 2 or more years out of cancer treatment
  • Be mentally capable of providing informed consent
  • Be reachable by telephone for screening and survey completion
  • Be a current smoker (defined as having taken one puff of a cigarette in the last 30 days)
  • Fluent in English

排除标准

  • Currently undergoing active treatment for cancer

结局指标

主要结局

The primary outcome is smoking cessation

时间窗: 15 months post BL

次要结局

  • Secondary outcome: cost-effectiveness, intervention dose delivered, reach, impact, quit attempts, motivation to quit, and use of pharmacotherapy(15 months post BL)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karen Emmons, PhD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (2)

Loading locations...

相似试验